Concepedia
Statistics
Publications
28
Citations
2.4K
H-Index
22
Active since
1978
Affiliations
Amgen (United States)(Current)
Scripps Clinic
University of Georgia
Novartis (Switzerland)
Inserm
G. Duke Virca is an author at Amgen (United States) specializing in medicine, immunology, and biochemistry.
Top concepts
MedicineImmunologyBiochemistryInflammationCell SignalingCell BiologyNatural SciencesSignal TransductionCellular BiochemistryCell Physiology
Publications per year
1978–2011
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs
Jennifer E. Towne, Kirsten E. Garka, Blair R. Renshaw et al. · Journal of Biological Chemistry · 2004 · 413 citations · Full text
Activation of Nuclear Transcription Factor NF-κB by Interleukin-1 Is Accompanied by Casein Kinase II-mediated Phosphorylation of the p65 Subunit
Timothy A. Bird, Kenneth Schooley, Steven Dower et al. · Journal of Biological Chemistry · 1997 · 207 citations · Full text
Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.
John C. Mathison, G. Duke Virca, Eliza B. Wolfson et al. · Journal of Clinical Investigation · 1990 · 205 citations · Full text
The Soluble Form of IL-1 Receptor Accessory Protein Enhances the Ability of Soluble Type II IL-1 Receptor to Inhibit IL-1 Action
Dirk E. Smith, Roberta Hanna, Della Friend et al. · Immunity · 2003 · 181 citations · Full text
Inflammation, Cytokine, Inhibit Il-1 Action +7
Lipopolysaccharide Induces Hyporesponsiveness to Its Own Action in RAW 264.7 Cells
G. Duke Virca, Sang Yeop Kim, Keith B. Glaser et al. · Journal of Biological Chemistry · 1989 · 161 citations · Full text
1–5 of 28